These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11033826)

  • 1. Longer time to tumor progression with exemestane vs tamoxifen in advanced breast cancer.
    Oncology (Williston Park); 2000 Sep; 14(9):1291, 1294. PubMed ID: 11033826
    [No Abstract]   [Full Text] [Related]  

  • 2. Exemestane or tamoxifen?
    Atkins CD
    Lancet; 2007 May; 369(9573):1600; author reply 1600-1. PubMed ID: 17499597
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant treatment of breast cancer with exemestane.
    Vakaet LA; De Neve W
    N Engl J Med; 2004 Jul; 351(1):100-2; author reply 100-2. PubMed ID: 15237462
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant treatment of breast cancer with exemestane.
    Kunkler IH
    N Engl J Med; 2004 Jul; 351(1):100-2; author reply 100-2. PubMed ID: 15229316
    [No Abstract]   [Full Text] [Related]  

  • 5. Time to TEAM: exemestane, or tamoxifen then exemestane?
    Coombes RC; Kilburn LS
    Lancet; 2011 Jan; 377(9762):280-1. PubMed ID: 21256370
    [No Abstract]   [Full Text] [Related]  

  • 6. Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.
    Prescrire Int; 2001 Aug; 10(54):108-9. PubMed ID: 11718178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant hormone therapy for breast cancer: alternatives to tamoxifen.
    Prescrire Int; 2005 Jun; 14(77):108-10. PubMed ID: 15984106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
    Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
    Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumoristatic action of tamoxifen: experimental evidence for clinical application in stage I and II breast cancer.
    Jordan VC
    J Chemother; 1989 Jul; 1(4 Suppl):1144-7. PubMed ID: 16312810
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of tamoxifen as treatment of breast cancer.
    Powles TJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients.
    Pritchard KI
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4356s-4359s; discussion 4411s-4412s. PubMed ID: 11916225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
    Patterson JS; Plourde PV; Milbauer A
    J Clin Oncol; 1996 Oct; 14(10):2886-7. PubMed ID: 8874352
    [No Abstract]   [Full Text] [Related]  

  • 13. Exemestane with ovarian suppression in premenopausal breast cancer.
    Prasad V
    N Engl J Med; 2014 Oct; 371(14):1358. PubMed ID: 25271613
    [No Abstract]   [Full Text] [Related]  

  • 14. Exemestane with ovarian suppression in premenopausal breast cancer.
    Chlebowski RT; Pan K
    N Engl J Med; 2014 Oct; 371(14):1358. PubMed ID: 25271612
    [No Abstract]   [Full Text] [Related]  

  • 15. Exemestane with ovarian suppression in premenopausal breast cancer.
    Amoroso V; Berruti A; Simoncini E
    N Engl J Med; 2014 Oct; 371(14):1357. PubMed ID: 25271611
    [No Abstract]   [Full Text] [Related]  

  • 16. Exemestane with ovarian suppression in premenopausal breast cancer.
    Pagani O; Regan MM; Francis PA; ;
    N Engl J Med; 2014 Oct; 371(14):1358-9. PubMed ID: 25271610
    [No Abstract]   [Full Text] [Related]  

  • 17. More large trials needed to decide best duration of treatment with tamoxifen.
    Cameron DA
    BMJ; 1998 Nov; 317(7171):1524. PubMed ID: 9831594
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriasis and tamoxifen therapy: a case report.
    Ferrari VD; Jirillo A
    Tumori; 1996; 82(3):262-3. PubMed ID: 8693608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making use of modeling and simulations: Towards individualized tamoxifen therapy in breast cancer
.
    Klopp-Schulze L; Joerger M; Wicha SG; Parra-Guillen ZP; Kloft C
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):690-691. PubMed ID: 27641215
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen reduces breast cancer by a third in high risk women.
    Mayor S
    BMJ; 2002 Sep; 325(7365):613. PubMed ID: 12242163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.